| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |